Melanoma Brain Metastasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-01-02
Clinical Trial Update: NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis [Phase 1, Phase 2]
A phase 1/2 trial of NovoTTF-200A in combination with pembrolizumab for metastatic melanoma with brain metastases has been withdrawn.